These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37631487)

  • 21. Can dosage form-dependent food effects be predicted using biorelevant dissolution tests? Case example extended release nifedipine.
    Andreas CJ; Tomaszewska I; Muenster U; van der Mey D; Mueck W; Dressman JB
    Eur J Pharm Biopharm; 2016 Aug; 105():193-202. PubMed ID: 27322002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biorelevant in vitro performance testing of orally administered dosage forms-workshop report.
    Reppas C; Friedel HD; Barker AR; Buhse LF; Cecil TL; Keitel S; Kraemer J; Morris JM; Shah VP; Stickelmeyer MP; Yomota C; Brown CK
    Pharm Res; 2014 Jul; 31(7):1867-76. PubMed ID: 24643933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies and therapeutic opportunities for the delivery of drugs to the esophagus.
    Zhang L; Russell D; Conway BR; Batchelor H
    Crit Rev Ther Drug Carrier Syst; 2008; 25(3):259-304. PubMed ID: 18540840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is rat a good model for assessment of particulate-based taste-masked formulations?
    Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
    Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
    Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Development and In vitro/Ex vivo Evaluation of Mucoadhesive Buccal Film of Benzydamine Hydrochloride for the Effective Treatment of Aphthous Stomatitis.
    Sharma D; Sharma A; Garg R
    Recent Pat Drug Deliv Formul; 2018; 12(4):277-294. PubMed ID: 30706830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status and advances in esophageal drug delivery technology: influence of physiological, pathophysiological and pharmaceutical factors.
    Lim AW; Talley NJ; Walker MM; Storm G; Hua S
    Drug Deliv; 2023 Dec; 30(1):2219423. PubMed ID: 37344759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a mucoadhesive dosage form for vaginal administration.
    Ceschel GC; Maffei P; Lombardi Borgia S; Ronchi C; Rossi S
    Drug Dev Ind Pharm; 2001 Jul; 27(6):541-7. PubMed ID: 11548861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the GastroDuo to study the interplay of drug release and gastric emptying in case of immediate release Aspirin formulations.
    Schick P; Sager M; Voelker M; Weitschies W; Koziolek M
    Eur J Pharm Biopharm; 2020 Jun; 151():9-17. PubMed ID: 32268191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of disintegration rate is important for predicting the oral absorption of solid dosage forms containing poorly soluble weak base drugs.
    Nakamura K; Kambayashi A; Onoue S
    Eur J Pharm Biopharm; 2022 Nov; 180():23-32. PubMed ID: 36154905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Investigation into the Relationship between Xanthan Gum Film Coating Materials and Predicted Oro-Esophageal Gliding Performance for Solid Oral Dosage Forms.
    Drumond N; Stegemann S
    Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33419280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new biorelevant dissolution method for orodispersible films.
    Krampe R; Sieber D; Pein-Hackelbusch M; Breitkreutz J
    Eur J Pharm Biopharm; 2016 Jan; 98():20-5. PubMed ID: 26515261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functionality and Acceptance of the EsoCap System-A Novel Film-Based Drug Delivery Technology: Results of an In Vivo Study.
    Rosenbaum C; Grimm M; Krause J; Rump A; Kessler R; Hosten N; Weitschies W
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34199636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution Profile of Mefenamic Acid Solid Dosage Forms in Two Compendial and Biorelevant (FaSSIF) Media.
    Nurhikmah W; Sumirtapura YC; Pamudji JS
    Sci Pharm; 2016; 84(1):181-90. PubMed ID: 27110508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of esophageal peristalsis by alterations of body position. Effect of bolus viscosity.
    Dooley CP; Schlossmacher B; Valenzuela JE
    Dig Dis Sci; 1989 Nov; 34(11):1662-7. PubMed ID: 2582978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biorelevant in-vitro performance testing of orally administered dosage forms.
    Reppas C; Vertzoni M
    J Pharm Pharmacol; 2012 Jul; 64(7):919-30. PubMed ID: 22686340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular smooth muscle contributes to esophageal shortening during peristalsis.
    Vegesna AK; Chuang KY; Besetty R; Phillips SJ; Braverman AS; Barbe MF; Ruggieri MR; Miller LS
    World J Gastroenterol; 2012 Aug; 18(32):4317-22. PubMed ID: 22969194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.